Status:
COMPLETED
Treatment of Early Hypertension Among Persons Living With HIV in Haiti
Lead Sponsor:
Weill Medical College of Cornell University
Collaborating Sponsors:
Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic
Fogarty International Center of the National Institute of Health
Conditions:
HIV/AIDS
Pre Hypertension
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
The investigators are conducting an unblinded pilot randomized control trial of 250 persons living with HIV (PLWH), aged 18-65 years, who receive antiretroviral therapy care at Haitian Group for the S...
Detailed Description
The investigators propose a pilot randomized controlled trial to evaluate antihypertensive treatment among people living with HIV (PLWH) with pre-hypertension (pre-HTN) at GHESKIO. This study will pro...
Eligibility Criteria
Inclusion
- PLWH 18-65 years of age
- ART duration ≥ 1 year, stable regimen ≥ 6 months
- HIV 1-RNA \< 1,000 copies/mL within past 12 months
- Pre-HTN (SBP 120-139 or DBP 80-89 mm Hg)
- No current antihypertensive treatment
- Receives HIV care at GHESKIO
- Willing to provide consent
Exclusion
- Pregnancy
- Kidney disease or diabetes
- On protease inhibitor/ritonavir
- Advanced illness with limited life expectancy
- Plans to move out of the area within the next year
- Clinician determination that patient is unstable on ART
Key Trial Info
Start Date :
February 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2023
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04692467
Start Date
February 26 2021
End Date
December 30 2023
Last Update
April 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GHESKIO
Port-au-Prince, Haiti